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Abstract  
Context: Laurelia sempervirens (R. et P.) Tul., is an evergreen tree that growths in southern Chile, its leaves and bark are used in folk medicine as an 
infusion. Objective: The antimicrobial activities of the essential oil and ethyl acetate extract obtained from the bark of Laurelia sempervirens were 
investigated. Materials and methods: Ethyl acetate extract and essential oil were analyzed by GC- mass and the antimicrobial activity was investigated 
against gram positive and gram negative bacteria. Results: The extract and essential oil showed a strong antimicrobial activity against bacteria such as 
Acinetobacter baumanii, a relevant world nosocomial pathogen Discussion and conclusion: These findings demonstrate that the ethyl acetate extract and 
essential oil of L.sempervirens bark have excellent antimicrobial activities and thus have great potential as a source for natural health products.  
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Resumen 
Contexto: Laurelia sempervirens (R. et P.) Tul., es un árbol de hoja perenne que crece en el sur de Chile, sus hojas y corteza se utilizan en medicina popular 
como infusión. Objetivo: Investigar la actividad antimicrobiana del aceite esencial y el extracto de acetato de etilo obtenido de la corteza de Laurelia 
sempervirens. Materiales y métodos: El extracto de acetato de etilo y el aceite esencial se analizaron por GC-masa y la actividad antimicrobiana se analizó 
contra bacterias gram positivas y gram negativas. Resultados: El extracto y aceite esencial evidenció una fuerte actividad antimicrobiana frente a la bacteria, 
Acinetobacter baumanii patógeno que causa infecciones nosocomiales de relevancia mundial. Discusión y conclusiones: Estos hallazgos demuestran que el 
extracto de acetato de etilo y aceite esencial de corteza de L.sempervirens tienen excelentes actividades antimicrobianas y por lo tanto tienen un gran potencial 
como fuente de productos naturales para la salud.  
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INTRODUCTION 
Considering the knowledge of Chilean indigenous 
cultures on the use of medicinal plants, we conducted 
the research on those that present obvious biological 
activities, being Laurelia sempervirens one of the most 
used. Laurelia sempervirens, also called Chilean 
Laurel, is a species of evergreen tree endemic to Chile. 
Leaves of Laurelia sempervirens were used by the 
Mapuche amerindians for treating headache and as a 
diuretic. Intravenous administration of a 
hydroalcoholic L. sempervirens extract to rats, elicited 
a hypotensive response. Bioassay-guided isolation of 
the active Laurel metabolites led to the alkaloid 
laurotetanine as the main hypotensive principle of L. 
sempervirens leaves (Schmeda-Hirschmann et al., 
1994). Bittner et al., 2009 demonstrate the fungistatic 
activity of essential oil of Laurelia sempervirens 
leaves.  Cassels and Urzúa in 1985 reported the 
isolation alkaloids (obaberine, thalrugosine, and 
oxyacanthine) of the stem bark. Liriodenine and 
oxonantenina present in bark extracts are powerful 
broad spectrum antimicrobial agents (Hufford et al., 
1980). In recent studies by Mølgaard et al., 2011 
demonstrate the antimicrobial activities of aqueous 
and ethanolic extracts of leaves, these results support 
the previous comprehensive reports regarding the 
antimicrobial and/or cytotoxic effects of Laurelia 
sempervirens. 
Based on these data, we carried out the study 
of compounds through joined gas chromatography 
present in the phase of ethyl acetate and in the 
essential oil of L. sempervirens bark. In addition, we 
perform tests on inhibitory activity in bacterial 
development considered a problem for its frequency 
and ability to present resistance to commonly used 
antibiotics like Acinetobacter baumanni, Pseudomona 
aeruginosa and Staphylococcus aureus (Storti et al., 
2005; Akers et al., 2010; Perazzi et al., 2010). 
 
EXPERIMENTAL SECTION 
Plant Material  
The samples of L. sempervirens were collected 
 in September 2003, from trees growing in plantations 
located at the Arboretum of the Universidad Austral de 
Chile, Valdivia, Chile. Number of herbal 17472. 
 
Microorganisms 
Staphylococcus aureus ATCC29583, Pseudomonas 
aeruginosa ATCC 27853, Bacillus subtilis 
ATCC6633, Salmonella sp108,109; Serratia 
marcescens 1332-2; Pseudomonas aeruginosa1020-
1,1020-2,1048-2; Acinetobacter baumannii 999, 
Staphylococcus aureus 2312 (not ATCC bacteria was 
isolated from clinical samples at Regional Hospital, 
Valdivia, Chile) cultures were obtained  from the 
culture collections of Clinical Microbiology 
Department of Universidad Austral de Chile.   
 
Essential oil extraction 
Fresh bark of Laurelia sempervirens (4 kg) was steam-
distilled for 5 h using a Clevenger type apparatus. 
Essential oil yielded 1.0%. The essential oil obtained 
was stored at 4º C and used in biological assays 
without further purification. 
 
Preparation of ethyl acetate extract 
To extract bioactive compounds, 2.7 kg of Laurelia 
sempervirens bark with 20 L of ethyl acetate were 
processed twice. The resulting solution was brought to 
dryness in a Büchi R-114 rotary evaporator with Büchi 
Waterbath thermoregulator bath B-480 at a 
temperature of 60º C.  The sample was treated with hot 
water to remove chlorophyll and then it was dried. A 
fraction was used for chromatographic analysis. 28.6 g 
of this extract was suspended in 100 mL of ethyl 
acetate providing in this way a solution of 0.286 g/mL, 
which was used for biological tests.  
 
Antimicrobial Assays 
To evaluate the antibacterial activity, the hole-plate 
agar diffusion method was implemented
 
(Van den 
Berghe and Vlietinck, 1991) 4-5 colonies were taken 
from the microorganisms studied. The colonies were 
re-suspended in physiological saline solution, in 
duplicate, to 0.5 Mac-Farland concentration (10
8
 
CFU/mL). The bacterial suspension was uniformly 
spread by using sterile cotton swab on a sterile Petri 
dish MH agar. After letting it dry for 10-15 minutes, 6 
mm diameter holes were cut in the agar at 24 mm 
distance from each other. 20 μL of serial dilutions 
obtained from the initial extract were placed in each 
well. These dilutions had concentrations ranging from 
7200 μg/mL to 0.72 μg/mL. Plates were incubated 
overnight at 35º C, under aerobic conditions. After 
incubation, confluent bacterial growth was observed. 
The inhibition zone around the hole was measured 
with a caliper. Minimum inhibition concentration 
(MIC) was defined as the lowest concentration that 
inhibited visible growth. 
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Essential oil was assayed to each 
microorganism in the same way that ethyl acetate 
extract. 20 µL of serial dilutions in n-hexane 1:10; 
1:100; 1:1000; 1:10000 were assayed. Negative 
controls were performed with pure solvent. All the 
experiments were repeated five times. 
Inhibition assays were performed by adding 
antibiotic clinical samples as described in NCCLS 
2003 and CLSI, 2009 in order to compare with the 
results obtained after addition of ethyl acetate extract 
and essential oil from bark. 20 uL of either 70 ug/mL 
gentamicin, amikacin and ciprofluoxacine clinical 
samples were added. 
 
Antibiotics assay 
To determine the sensitivity of microorganism to 
antibiotics (MICs) of amikacin (AKN), gentamicin 
(GEN) and ciprofloxacine were obtained (CIPRO) in 
vitro through the inhibition zone determination 
method, as stated by microdilution NCCLS guidelines 
(National Committee for Clinical Laboratory 
Standards) and CLSI (Clinical and Laboratory 
Standards Institute) Salmonella sp. 108,109; Serratia 
marcescens 1332-2; Pseudomonas aeruginosa 1020-
1,1020-2,1048-2; Acinetobacter baumannii 999, 
Staphylococcus aureus 2312. Isolates from clinical 
samples and the ATCC species Staphylococcus aureus  
ATCC29583, Pseudomonas aeruginosa ATCC 27853, 
Bacillus subtilis ATCC6633. It has been reported that 
these bacterias are sensitive to these antibiotics 
(Fernandéz-Cuenca et al., 2004 and Zambrano et al., 
2004; Simberkoff et al., 1986). 
 
Chromatographic analysis 
The essential oil and ethyl acetate extract were diluted 
with n-hexane, 1 μL was sampled for the gas 
chromatography and analyzed in a chromatograph HP 
6890 equipped with a programmable temperature that 
vaporizes inlet (PTV). In addition, it was coupled to an 
HP 5973 mass selective detector (Hewlett-Packard, 
Palo Alto, CA, USA) in scan mode in order to 
determine the composition of extracts fractions. The 
injector temperature was maintained at 280º C in a 
pulsed splitless mode. A GC program temperature 
ramp was set at 70º C for 3 min. and then at a rate of 
10 ºC/min. up to 300º C was used to afford the best 
separation by using a capillary HP-5 MS column. The 
transfer line was maintained at 300º C. Mass spectra 
was obtained at 70 eV and compared through direct 
matching by using a NIST Mass Spectral Search 
Program and a NIST/EPA/NIH Mass Spectral Library 
(NIST, 1998). 
 
 
Data analysis 
Results were expressed as mean value ± standard error 
of growth inhibition halo diameters were obtained 
with ethyl acetate extract and essential oil of Laurelia 
sempervirens bark. To determine significant 
differences among inhibitory activity of Antibiotic and 
essential oil or antibiotic and ethyl acetate extract, a 
one way ANOVA was carried out using GraphPad 
Prism V5 software. P values less than 0.05 (p < 0.05) 
were considered as significant. 
 
RESULTS AND DISCUSSION 
Composition analysis of the ethyl acetate extract and 
essential oil by gas chromatography coupled to a 
mass selective detector 
Tables I and II show the data obtained from gas 
chromatographic analysis of the ethyl acetate extract 
and essential oil of Laurelia sempervirens bark. 
According to Cespedes et al., (2006) and Zapata 
(2010), the high antimicrobial activity of the essential 
oil and ethyl acetate extract from bark of L. 
sempervirens are not that surprising. This is because 
safrole (63.03 and 65.03% respectively) was one of the 
main metabolites in these samples. Safrole is also the 
main constituent (74.29%) present in the essential oil 
of Piper auritum. It has shown high Antimicrobial 
activity when was tested against Xanthomonas 
albilineans and Acidovorax avenae subsp. avenae 
(Sánchez et al., 2009) The other component of the 
ethyl acetate extract is (E)-5-prop-1-enyl) benzo [d] 
[1,3] dioxolan, better known as isosafrole (12.94%), a 
carcinogenic aromatic compound (Tulp and Bohlin, 
2004; Delaforge
 
et al., 1982). The isosafrole has two 
types of isomers and it is the precursor to the MDMA 
drug of abuse (known as ecstasy) and Spathulenol 
(6.60%) this sesquiterpene presents activity against 
Escherichia coli, Salmonella typhimurium and 
Staphylococcus aureus (de Souza et al., 2011). In 
essential oils we found 3-Carene and β-Caryophyllene, 
described in essential oils that present antimicrobial 
activity (Pichette et al., 2006; Oztürk et al., 2009). α-
Gurjunene was identified in the essential oil of tubers 
of Cyperus rotundus Linn. (Bisht et al., 2011), and 
showed antifungal activity against the pathogenic 
Trichophyton menthagrophytes (Flach et al., 2002). 
Finally, we note the presence of 3-Allyl-6-
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methoxyphenol, compound that has Antioxidant activity (Phutdhawong et al., 2007).  
 
Table I 
Volatile compounds identified in ethyl acetate extract from bark of Laurelia sempervirens. 
 
Compound RI Area (%) Identification 
Isosafrole 1177.5 12.94 RI, MS, Co-I 
Safrole 1292.6 63.03 RI,MS, Co-I 
Spathulenol 1457.2 6.60 RI, MS 
 
 
Table II 
Mayor compounds identified in essential oil from bark of Laurelia sempervirens. 
 
Compound RI Area (%) Identification 
α-Pinene 941,11 1.48 RI, MS 
Camphene 957,37 0.11 RI, MS 
α-Phellandrene 1009,80 0.33 RI, MS 
p-Cymene 1031,75 0.12 RI, MS 
β-Phellandrene 1037.66 1.08 RI, MS 
3-Carene 1070.4 0.42 RI, MS 
Isosafrole 1177.5 11.90 RI, MS, Co-I 
Safrole 1292,6 65.03 RI,MS, Co-I 
Piperonal 1358.2 0.37 RI, MS 
3-Allyl-6-methoxyphenol 1359.6 1.13 RI, MS 
β-Caryophyllene 1384.9 0.74 RI, MS 
α-Gurjunene 1396.6 0.24 RI, MS 
α-Humelene 1440.9 0.35 RI, MS 
Germacrene D 1444.8 2.33 RI, MS 
Spathulenol 1457.2 11.16 RI, MS 
α-Cadinol 1615,0 1.10 RI, MS 
Adams RP. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry; 4th Ed.; 
Allured Publishing Corporation: Carol Steam, 2007. 
 
Bacterial Development Inhibition 
The ethyl acetate extract and essential oil from bark of 
Laurelia sempervirens show strong and efficient 
antimicrobial activity against different types of 
bacteria. As shown in table III and IV, the extract and 
essential oil were tested against Acinetobacter 
baumanii, Staphylococcus aureus, Pseudomonas 
aeruginosa, Salmonella spp, Bacillus subtilis ATCC 
9799 and Serratia marcensens, High efficiency against 
these resistant and persistent microorganisms causing 
nosocomial infections was observed. The hole plate 
method was chosen because is a suitable diffusion 
technique for testing suspensions of plants extracts. In 
this method, the presence of particulate matter in the 
sample is much less likely to interfere with the 
diffusion of the antimicrobial substance into the agar 
than in the filter paper disc (Valgas et al., 2007). 
 
Minimum Inhibitory concentration (MIC) 
Previously defined as the minimum inhibitory 
concentration as the lowest concentration of pure 
compounds or greater dilution of essential oil that 
inhibited visible bacterial growth  using as control the 
pure solvent. In all cases we considered as bacterial 
growth inhibition when the inhibition halo was 1 mm 
in diameter at least.  The results are shown in tables III 
and IV.  
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Gram positive bacteria Staphylococcus aureus 
and Bacillus subtillis, and gram negatives: Salmonella 
spp, Serratia marcescens, Pseudomonas aeruginosa 
and Acinetobacter baumannii. An extensive literature 
describes the structural and physiological differences 
between gram (-) and gram (+) bacteria. However, 
Staphylococcus aureus, Serratia marcescens, 
Pseudomonas aeruginosa and Acinetobacter 
baumannii, represents a challenge for healthcare as a 
cause of hospital acquired infections, difficult to treat 
because they represent opportunistic pathogens 
multidrug resistant. In the hospital, they may be 
isolated from equipment and accessories, air 
conditioner ducts as well as the skin of workers and 
rarely cause infection in healthy persons (Harbarth et 
al., 2008; McGowan, 2006; Uduman et al., 2002; 
Hejazi and Falkiner, 1997). 
Multi-resistance to methicillin and other 
antibiotics by Staphylococcus aureus as reported, 
representing a high risk of infection in surgical 
patients (Harbarth et al., 2008). 
 
Table III 
Minimun Inhibitory concentration (μg/mL) of ethyl acetate extract from bark of Laurelia sempervirens 
 
Species Concentration (µg/ml) Average of inhibition halo 
(mm) 
Salmonella sp 72 12 
Acinetobacter baumanni 7 28 
Pseudomonas aeruginosa 1020 72 23 
Serratia marcescens 7200 14 
Bacillus subtilis 0.72 25 
Staphylococcus aureus 2312 72 17 
 
Serratia marcescens, classified as a member 
of the enterobacteriaceae, has been recognized because 
of resistance to a variety of antibiotics, including 
ampicillin, cephalosporins, quinolones and 
aminoglycosides (Hejazi and Falkiner, 1997) and is 
involved in various types of infection such as 
respiratory tract infections, urinary tract infections, 
neonatal sepsis and meningitis (Uduman et al., 2002). 
The high resistance to fluoroquinolones 
(ciprofloxacin) that nosocomial Pseudomonas shows 
is a worldwide problem in many hospitals and health 
services as reported by Van Eldere 2003. 
Pseudomonas aeruginosa has been isolated from 
nosocomial pneumonia, primary bacteraemias, 
with high mortality, particularly in immune-
compromised patients associated with ineffective 
empirical therapy in these infections (Van Eldere, 
2003). 
Acinetobacter baumannii is a multidrug 
resistant bacteria (Akers et al., 2010) able to develop 
microcolonies and microbial biofilms on materials for 
medical use such as catheters being the cause of 
bloodstream infections (Storti et al., 2005). 
In the last two decades Acinetobacter 
baumanni has emerged as a major relevant world 
nosocomial pathogen can be a causal agent of diseases 
like pneumonia, bacteremia, meningitis, soft tissue and 
urinary tract infections, associating to high mortality. 
(Diomedi, 2005).  
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Table IV 
Minimun Inhibitory concentration of essential oil from bark of Laurelia sempervirens. 
 
Species Dilution in n-hexane Average of inhibition halo 
(mm) 
Salmonella sp 1/10000 12 
Acinetobacter baumanni 1/10000 25 
Pseudomonas aeruginosa 1020 1/10000 23 
Serratia marcescens 1/10000 16 
Bacillus subtilis 1/10000 17 
Staphylococcus aureus 2312 1/10000 14 
 
The minimum inhibitory concentration of 
ethyl acetate extract among bacteria could be due to 
the strains origin. Those with greater susceptibility are 
those with greater possibility of presenting multi 
resistance activity due to its nosocomial origin.  
We can not compare the results of bacterial 
growth inhibition among ethyl acetate extract and 
essential oil, it is not possible because we could not 
determine the minimum inhibitory concentration for 
essential oil since in all cases inhibition was achieved 
with the maximum dilution tested 1/10000 (Table IV).  
However, we compare these results with the 
inhibitory capacity of clinically used antibiotics tested 
(Table V), calculating the ratios among the inhibition 
halos of ethyl acetate extract, essential oil and 
antibiotics (Graphic 1). 
From these results, highlight the activity of 
ethyl acetate extract (ratio inhibition halo/antibiotic 
inhibition halo = 4.7) and essential oil (ratio inhibition 
halo/antibiotic inhibition halo = 4.2) from bark of 
Laurelia sempervirens against Acinetobacter 
baumannii (Graphic 1). Results based on Salmonella 
spp. and Bacillus subtilis are significant but these are 
minor clinic significance. 
Our results show that the phytochemical study 
of native plants and subsequent biological tests are a 
way to get products with antimicrobial activity. It has 
been possible to characterize components of the 
essential oil through the method of GC-MS 
compounds, but this is not possible in ethyl acetate 
extract of Laurelia sempervirens, because GC-MS 
technique used for the volatile and nonvolatile be 
retained in the column and/or decomposed in injection. 
Biological activity of essential oil and ethyl acetate 
extract depends on their chemical composition and 
interaction among structural components. Even minor 
compounds can have a critical function (Zapata et al., 
2010), therefore we are not in a position to explain the 
different mechanisms of action. However, 
antimicrobial activity of essential oil and ethyl acetate 
extract obtained from Laurelia sempervirens bark was 
demonstrated against a multidrug resistant bacteria 
isolated from clinical specimens, nevertheless, toxic 
effects to humans should be evaluated in future 
studies. 
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Table V 
The susceptibility of the microorganisms to selected antibiotics. 
 
Species Concentration (µg/ml) 
Antibiotics 
Average of inhibition halo 
(mm) 
Salmonella sp (CIPRO)
a
          70 14 
Acinetobacter baumanni (AKN)
b
              70 6 
Pseudomonas aeruginosa 1020 ( GEN)
c                   
 70 15 
Serratia marcescens (CIPRO)
a                 
70 14 
Bacillus subtilis (GEN)
c
               70 21 
Staphylococcus aureus 2312 (GEN)
c                      
70 9 
a; Ciprofuoxacine, b; Amikacin, c; Gentamicin 
 
 
* The inhibition rate was calculated dividing the ethyl acetate extract and essential oil inhibition halo (mm) with 
respect to the antibiotic inhibition halo (mm) (table V). 
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CONCLUSIONS 
Antibiotics are an essential part of medicine. However, 
bacterial resistance emerges and reduce efficacy of 
antibiotics in the human population. At this point, the 
search of new compounds with potential effects 
against pathogenic bacteria is required (Morales et al., 
2003). Chilean flora is a potential source of bioactive 
compounds, including some with antimicrobial 
activity. 
These preliminary studies are highly 
interesting as they open new pathways for further 
studies, which would allow the validation of the 
traditional use of plants in the treatment of infections. 
The next step in our research is the isolation of pure 
compounds to determine their antibiotic activity and 
their mechanisms of action. Therefore, our study 
serves as a basis for new targets on molecular 
mechanisms of action for natural compounds. Our 
findings provide with new data to fight this pathogen 
and with new drugs that can be developed from natural 
products. 
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